PER 0.00% 7.8¢ percheron therapeutics limited

isis and anp to follow, page-6

  1. 35,729 Posts.
    lightbulb Created with Sketch. 554
    I still think the more likely outcome if pharmas impetus for Anitsense is building someone will just step in and aquire ISIS - i mean really it's still pocket change for the large cats with a MC under $1B still would make it very small in comparison to recent aquisitions & great value add for the entire portfolio if they see the value across the whole scope.

    FWIW Biogen Idec have the most effective MS treatment to date Tsybari with 70% reduction in relapses far greater than others although there are significant risks 1/1000 - it was temporarily pulled by FDA then reinstated with the TOUCH program aswell as some unfavourable side effects as is the case with all MS drugs - the winner for MS will be a cure although who knows when/if that will ever come - all drugs now only provide at best modeest effects in slowing progression, there has really not been a long enough period for any of these to properly view the effects both positive & negative over time. Personally i take no drugs for that reason & strict diet & lifestyle change can make MS manageable, slow progression & rate of relapses.

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.8¢
Change
0.000(0.00%)
Mkt cap ! $70.32M
Open High Low Value Volume
7.8¢ 7.9¢ 7.8¢ $16.54K 212.7K

Buyers (Bids)

No. Vol. Price($)
1 6454 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 12975 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.